Search results for "stereotactic radiotherapy"

showing 8 items of 8 documents

Radiosurgery as Treatment for Acoustic Neuroma. Ten Years’ Experience

2013

The acoustic neuroma is a benign tumour that usually affects the vestibular portion of the vestibulocochlear nerve. It represents 8% of all intracranial tumours and 80% of those arising at the cerebellopontine angle. There are 3 treatment options: microsurgery (the technique of choice), radiosurgery and observation. The objective of the study was to evaluate the results and side effects obtained using radiosurgery as treatment for acoustic neuroma.We performed a review of all patients treated with radiosurgery (Gamma Knife and linear accelerator) at doses of 1200-1300 cGy for unilateral acoustic neuroma in our hospital from January 1999 until January 2010. In all patients we evaluated the o…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAcoustic neuromaRadiosurgeryRadiosurgeryVestibulocochlear nerveStereotactic radiotherapyHearingotorhinolaryngologic diseasesmedicineHumansIntracranial tumoursAgedRetrospective Studiesbusiness.industryTreatment optionsNeuroma AcousticGeneral MedicineMiddle AgedMicrosurgerymedicine.diseaseCerebellopontine angleSurgeryFemalesense organsbusinessActa Otorrinolaringologica (English Edition)
researchProduct

Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study

2017

Abstract Introduction Aim of the present study is to evaluate homolateral and contralateral hippocampus (H-H, C-H, respectively) dose during Fractionated Stereotactic Radiotherapy (FSRT) or Radiosurgery (SRS) for brain metastases (BM). Materials & methods Patients with BM   3 months, were considered for SRS/FSRT (total dose 15–30 Gy, 1–5 fractions). For each BM, a Flattening Filter Free (FFF) Volumetric Modulated Arc Therapy (VMAT) plan was generated with one or two arcs. Hippocampi were not considered during optimizations phase and were contoured and evaluated retrospectively in terms of dose: the Dmedian, Dmean, D0.1cc and the V1Gy, V2Gy, V5Gy and V10Gy were analyzed. Results From April 2…

AdultMalemedicine.medical_treatmentBiophysicsGeneral Physics and AstronomyStereotactic fractionatedHippocampal formationRadiation DosageRadiosurgeryHippocampusRadiosurgery030218 nuclear medicine & medical imagingStereotactic radiotherapyYoung AdultPhysics and Astronomy (all)03 medical and health sciences0302 clinical medicineNuclear Medicine and ImagingStereotactic radiotherapymedicineHumansRadiology Nuclear Medicine and imagingIn patientHippocampiAgedAged 80 and overRadiotherapyBrain Neoplasmsbusiness.industryRadiotherapy DosageBrain metastasesGeneral MedicineMiddle AgedBrain metastases; Hippocampi; Radiotherapy; Stereotactic fractionated; Stereotactic radiotherapy; Biophysics; Radiology Nuclear Medicine and Imaging; Physics and Astronomy (all)Volumetric modulated arc therapyRadiation therapy030220 oncology & carcinogenesisTotal doseFemaleDose reductionParticle AcceleratorsRadiologybusinessNuclear medicinePhysica Medica
researchProduct

Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth …

2020

Aim This retrospective observational study evaluated the role of hypo-fractionated stereotactic radiotherapy (SRT) in patients with oligo-progressive metastatic renal cell carcinoma (mRCC) treated with first-line oral tyrosine kinase inhibitors (TKI). Data on local control, delay of further progression, and safety are reported. Patients and methods Between January 2010 and December 2016, 28 patients with mRCC who showed oligo-progressive disease while receiving first-line pazopanib were treated with hypofractionated SRT to progressive metastatic sites to delay the change of systemic therapy. First and second progression-free survival (PFS-1 and PFS-2) were recorded, as well as objective res…

OncologyAdultMaleCancer Researchmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentTyrosine-kinase inhibitorDisease-Free SurvivalMetastasisPazopanibRenal cell carcinomaInternal medicinetyrosine kinase inhibitorsmedicinepazopanibmetastasisHumansNeoplasm MetastasisCarcinoma Renal CellProtein Kinase InhibitorsAgedRetrospective Studiesbusiness.industryCarcinomaRenal CellRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseasemetastasis; pazopanib; Renal cell carcinoma; stereotactic radiotherapy; tyrosine kinase inhibitors; Adult; Aged; Carcinoma Renal Cell; Disease-Free Survival; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Protein Kinase Inhibitors; Retrospective StudiesRenal cell carcinomaKidney NeoplasmsRadiation therapyOncologyToxicitystereotactic radiotherapyFemalebusinessTyrosine kinasemedicine.drug
researchProduct

Stereotactic Radiosurgery of Deeply Seated Low Grade Gliomas

1994

The authors report the results of a series of 16 cases of low-grade gliomas in whom radiosurgery was performed. This series started in 1977. All the tumours received a single radiosurgical session (with a mean dose of 21.7 Gy, 5–10mm. collimator; one patient received two sessions and in another patient two different targets were irradiated in the same session). Prior to radiosurgery, six patients received conventional external fractionated radiotherapy, with two lateral fields of up to 10 × 10 cm. and a mean dose of 55.1 Gy. and another six patients with tumours less than 5 cm. in diameter, received stereotactic radiotherapy using four fields of up to 5 × 5 cm. and a mean dose of 53.1 Gy. I…

Stereotactic radiotherapyConventional fractionationFractionated radiotherapybusiness.industrymedicine.medical_treatmentmedicineNuclear medicinebusinessRadiosurgery
researchProduct

Stereotactic Radiotherapy plus Radiosurgical Boost in the Treatment of Large Cerebral Arteriovenous Malformations

1993

Small sized AVMs respond well to stereotactic radiosurgery, while larger AVMs do poorly with stereotactic radiosurgery or stereotactic fractionated radiotherapy. A combination of both methods is proposed for the treatment of these larger lesions.

medicine.medical_specialtyFractionated radiotherapymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentRadiosurgeryCerebral arteriovenous malformationsRadiation therapyStereotactic radiotherapyStereotaxic techniquemedicineIntracranial Arteriovenous MalformationsRadiologybusinessCerebral angiography
researchProduct

Antithrombotic therapy of Cerebral cavernous malformations

2020

Abstract Cavernous malformations are recognized as the most common vascular anomalies in the brain, that often lead to hemorrhage with neurological symptoms. Usually the treatment is surgical removal or stereotactic radiotherapy. We present a case of a slow-flow vascular anomaly located in the cavernous sinus with recurrent partial thrombotic areas. Inspired by treatment of peripheral venous anomalies antithrombotic therapy was initiated instead of surgery or stereotactic radiotherapy. This led to complete spontaneous resolution of the lesion and normalization of symptoms within nine months. The patient never showed any symptoms over a period of eight years while continuing antithrombotic t…

medicine.medical_specialtylcsh:SurgeryCerebral cavernous malformationslcsh:RC346-429Vascular anomalyLesionStereotactic radiotherapySurgical removalAntithromboticmedicinelcsh:Neurology. Diseases of the nervous systemAntithrombotic therapybusiness.industryCerebral cavernous malformationsTreatment of peripheral venous anomaliesAntithrombotic therapy ; Cerebral cavernous malformations ; Slow-flow vascular anomaly ; Intracerebral venous anomaly ; Treatment of peripheral venous anomalieslcsh:RD1-811Cavernous malformationsmedicine.diseaseIntracerebral venous anomalySlow-flow vascular anomalyCavernous sinusSurgeryNeurology (clinical)Radiologymedicine.symptombusinessInterdisciplinary Neurosurgery
researchProduct

Manejo de schwannoma vestibular con radiaciones : experiencia del IVO

2013

A partir de la década de los 70, nace la radiocirugía (RC) como tratamiento alternativo a la cirugía convencional en el tratamiento de los schwannomas vestibulares(SV). Poco a poco dicha técnica, ha ido desbancando a la microcirugía alcanzando cifras del 58 % de tratamientos de RC frente a la cirugía convencional. En el presente estudio analizamos el resultado de 167 tumores tratados con radiaciones (bien con dosis única (RC) o con dosis fraccionada, RT Estereotáctica Fraccionada (RTEF), determinando el control local y las complicaciones como tratamiento del SV. Analizamos los resultados en función de la tecnología utilizada para tratarlos, bien colimadores cilíndricos o bien micromutilámin…

schwannoma vestibularUNESCO::CIENCIAS MÉDICASradiosurgerystereotactic radiotherapy:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Stereotaktisten annossuunnitelmien verifiointi Compass-järjestelmällä

2016

sädehoitostereotaktinen sädehoitoalgoritmitlaskentamallitVMATstereotactic radiotherapyalgorithmsradiotherapy
researchProduct